876

News

Novo Nordisk to slash its insulin prices in the US

Christian Wenande
March 15th, 2023


This article is more than 1 year old.

Move by Danish pharma giant comes in the wake of lawsuit in California and at the urging of President Biden

Novo Nordisk has responded to Biden’s call to reduce prices (photo: Novo Nordisk)

Novo Nordisk made an inauspicious start to 2023 in the US when it was among six firms sued by the state of California for driving up the cost of insulin.

That seems to have spurred the Danish pharma company into action, and it was announced this week that it intends to drastically cut the cost of its insulin medication products by the start of 2024.

“We have been working to develop a sustainable path forward that balances patient affordability, market dynamics and evolving policy changes,” said Steve Albers, the senior vice president of market access & public affairs at Novo Nordisk.

“Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulin – a responsibility we take seriously.” 

READ ALSO: California suing Novo Nordisk for “driving up the cost” of insulin

Pressure from the Prez
Novo Nordisk said it would slash the price of its insulin products – including the likes of Levemir, Novolin and NovoLog – by up to 75 percent.

The issue of pharma companies overcharging for their products reached the halls of the White House, where President Joe Biden called for pharma companies to voluntarily bring down the prices for the good of everyone.

Novo Nordisk competitor Eli Lilly responded weeks ago by announcing it would significantly reduce its insulin prices this year.

“For far too long, American families have been crushed by drug costs many times higher than what people in other countries are charged for the same prescriptions. Insulin costs less than $10 to make, but Americans are sometimes forced to pay over $300 for it. It’s flat wrong,” said Biden.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”